Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
33.30
-0.27 (-0.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.16 billion as of April 25, 2025. Its market cap has decreased by -5.92% in one year.
Market Cap
2.16B
Enterprise Value
1.40B
1-Year Change
-5.92%
Ranking
Category
Stock Price
$33.30
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.16B, an increase of 159.12%. That is a compound annual growth rate of 22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 2.18B | -16.35% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.12B |
| UnitedHealth Group | 388.56B |
| Johnson & Johnson | 371.12B |
| AbbVie | 314.06B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 222.83B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |